XORTX Therapeutics Inc. (XRTX)
$1.56-7.14%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $434,443
- Beta
- 0.08
- P/E (TTM)
- -0.31
- Short % float
- 24.61%
- Days to cover
- 1.0
- SI change
- -19.8%
- 1W
- -10.86%
- 1M
- -17.02%
- vs SPY 1W
- -10.72%
- vs SPY 1M
- -19.53%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on XRTX?
- LOPJLB’s latest quantitative signal on XORTX Therapeutics Inc. (XRTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is XRTX in?
- XORTX Therapeutics Inc. (XRTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does XORTX Therapeutics Inc. (XRTX) do?
- XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kid…